Studies
Pathogenesis and Immunity in Endemic Burkitt Lymphoma
Pathogenesis and Immunity in Endemic Burkitt Lymphoma
Request Access
Overview
Selected Publications (7)
A New Hope for CD56negCD16pos NK Cells as Unconventional Cytotoxic Mediators: An Adaptation to Chronic Diseases
C. Forconi, C. Oduor, P. Oluoch, et al.. (2020). Frontiers in Cellular and Infection Microbiology. Cited 54 times.
https://doi.org/10.3389/fcimb.2020.00162
Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort study
G. Buckle, L. Maranda, J. Skiles, et al.. (2016). International Journal of Cancer. Cited 48 times.
https://doi.org/10.1002/ijc.30170
Integrative microRNA and mRNA deep-sequencing expression profiling in endemic Burkitt lymphoma
C. Oduor, Yasin Kaymaz, K. Chelimo, et al.. (2017). BMC Cancer. Cited 26 times.
https://doi.org/10.1186/s12885-017-3711-9
Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma
C. Oduor, Mercedeh Movassagh, Yasin Kaymaz, et al.. (2017). Frontiers in Microbiology. Cited 24 times.
https://doi.org/10.3389/fmicb.2017.00501
Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences.
Yasin Kaymaz, C. Oduor, Hongbo Yu, et al.. (2017). Molecular cancer research : MCR. Cited 19 times.
https://doi.org/10.1158/1541-7786.MCR-16-0305
Sensitive detection of EBV microRNAs across cancer spectrum reveals association with decreased survival in adult acute myelocytic leukemia
Mercedeh Movassagh, C. Oduor, C. Forconi, et al.. (2019). Scientific Reports. Cited 9 times.
https://doi.org/10.1038/s41598-019-56472-1
Endemic Burkitt lymphoma avatar mouse models for exploring inter-patient tumor variation and testing targeted therapies
Priya Saikumar Lakshmi, C. Oduor, C. Forconi, et al.. (2023). Life Science Alliance. Cited 7 times.
https://doi.org/10.26508/lsa.202101355
